Latest Regulatory Development News

Booster Innovation Fund reported a $1.593 million profit for the year ended March 2026, supported by increased net assets. However, valuation risks persist due to early-stage investments and recent capital raises at lower prices.

Emyria has trained its first cohort of 31 clinicians in New South Wales, paving the way for its inaugural Sydney Empax clinic at Matilda Nepean, scheduled to open in Q3 2026.

Sweden's Parliament has amended legislation to remove uranium mining from nuclear facility regulations, simplifying permits and strengthening Aura Energy's prospects for its Häggån uranium deposit.

Nordic Resources has punched a new high-grade gold assay record at its Kopsa project in Finland, confirming a significant northern extension to the deposit. Early 2026 drilling reveals grades far surpassing previous intersections, setting the stage for a resource update later this year.

Optiscan and Mayo Clinic have completed all key engineering milestones in their two-year partnership to develop a digital endomicroscopic imaging system for robotic surgery, extending their agreement to support further clinical and commercial planning.

Cosmos Exploration has finalised its acquisition of EAU Lithium, issuing 108 million shares to former EAU shareholders and appointing James Durrant as Chairman to drive its Bolivian lithium ambitions.

Cauldron Energy has outlined a substantial new uranium exploration target on recently acquired tenements adjacent to Paladin’s Manyingee deposit, underpinning Yanrey’s growing status as a major uranium province in Western Australia.

ASX Limited projects a significant 18-21% rise in expenses for FY27 driven by technology modernisation and regulatory response, while increasing capital expenditure guidance to up to $200 million.

Bendigo and Adelaide Bank reported a slight increase in its Common Equity Tier 1 ratio to 11.38% for the quarter ended March 2026, driven by net profit and capital inflows. Risk-weighted assets rose 1.75%, largely due to loan portfolio expansion and a new operational risk capital overlay.

General Capital Limited reported an 18% increase in revenue to $26.8 million for the year ended March 2026, while net profit after tax held steady at $2.7 million amid economic uncertainty and a goodwill impairment. The company declared a fully imputed final dividend, signalling confidence despite regulatory challenges.

The Australian Treasurer has mandated the disposal of over 1.6 billion shares held by foreign entities in Northern Minerals, intensifying regulatory scrutiny of foreign ownership in this critical rare earths company.

Pacific Edge launches a NZ$6 million retail share offer at NZ$0.17 per share following a NZ$25.4 million institutional placement, aiming to strengthen its balance sheet and support Medicare reimbursement efforts for its bladder cancer diagnostics.